Academic literature on the topic 'Therapeutics'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Therapeutics.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Therapeutics"
Misselbrook, David. "Therapeutics?" British Journal of General Practice 71, no. 713 (November 25, 2021): 553. http://dx.doi.org/10.3399/bjgp21x717845.
Full textAzimi, A., S. Kuznecovs, J. Kuznecovs, A. Blazejczyk, M. Switalska, S. Chlopicki, A. Marcinek, et al. "Therapeutics." Annals of Oncology 23, suppl 5 (June 1, 2012): v23—v32. http://dx.doi.org/10.1093/annonc/mds162.
Full textJoyce, David A., and Kenneth F. Ilett. "Therapeutics." Medical Journal of Australia 161, no. 10 (November 1994): 622–26. http://dx.doi.org/10.5694/j.1326-5377.1994.tb127645.x.
Full textZipursky, Robert. "THERAPEUTICS." Schizophrenia Research 153 (April 2014): S65. http://dx.doi.org/10.1016/s0920-9964(14)70209-9.
Full textVan Zeeland, Yvonne R. A. "Therapeutics." Veterinary Clinics of North America: Exotic Animal Practice 21, no. 2 (May 2018): i. http://dx.doi.org/10.1016/s1094-9194(18)30020-3.
Full textvan Zeeland, Yvonne R. A. "Therapeutics." Veterinary Clinics of North America: Exotic Animal Practice 21, no. 2 (May 2018): xiii—xv. http://dx.doi.org/10.1016/j.cvex.2018.02.001.
Full textAlisi, Anna, Sara Tomaselli, Clara Balsano, and Angela Gallo. "Hepatitis C virus therapeutics: Editing enzymes promising therapeutic targets?" Hepatology 54, no. 2 (July 25, 2011): 742. http://dx.doi.org/10.1002/hep.24409.
Full textBarish, Robert A., and Jerome F. X. Naradzay. "Ophthalmologic Therapeutics." Emergency Medicine Clinics of North America 13, no. 3 (August 1995): 649–67. http://dx.doi.org/10.1016/s0733-8627(20)30611-8.
Full textGreish, Khaled, Jun Fang, Takao Inutsuka, Akinori Nagamitsu, and Hiroshi Maeda. "Macromolecular Therapeutics." Clinical Pharmacokinetics 42, no. 13 (2003): 1089–105. http://dx.doi.org/10.2165/00003088-200342130-00002.
Full textKatsarou, Angeliki, and Kostas Pantopoulos. "Hepcidin Therapeutics." Pharmaceuticals 11, no. 4 (November 21, 2018): 127. http://dx.doi.org/10.3390/ph11040127.
Full textDissertations / Theses on the topic "Therapeutics"
Lopez, Aguilar Aime. "Peptides as therapeutics." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:d893e962-5cb9-4d50-bbe1-c5183418295c.
Full textBalivada, Sivasai. "Cell mediated therapeutics for cancer treatment: tumor homing cells as therapeutic delivery vehicles." Diss., Kansas State University, 2013. http://hdl.handle.net/2097/16890.
Full textDepartment of Anatomy and Physiology
Deryl L. Troyer
Many cell types were known to have migratory properties towards tumors and different research groups have shown reliable results regarding cells as delivery vehicles of therapeutics for targeted cancer treatment. Present report discusses proof of concept for 1. Cell mediated delivery of Magnetic nanoparticles (MNPs) and targeted Magnetic hyperthermia (MHT) as a cancer treatment by using in vivo mouse cancer models, 2. Cells surface engineering with chimeric proteins for targeted cancer treatment by using in vitro models. 1. Tumor homing cells can carry MNPs specifically to the tumor site and tumor burden will decrease after alternating magnetic field (AMF) exposure. To test this hypothesis, first we loaded Fe/Fe3O4 bi-magnetic NPs into neural progenitor cells (NPCs), which were previously shown to migrate towards melanoma tumors. We observed that NPCs loaded with MNPs travel to subcutaneous melanoma tumors. After alternating magnetic field (AMF) exposure, the targeted delivery of MNPs by the NPCs resulted in a mild decrease in tumor size (Chapter-2). Monocytes/macrophages (Mo/Ma) are known to infiltrate tumor sites, and also have phagocytic activity which can increase their uptake of MNPs. To test Mo/Ma-mediated MHT we transplanted Mo/Ma loaded with MNPs into a mouse model of pancreatic peritoneal carcinomatosis. We observed that MNP-loaded Mo/Ma infiltrated pancreatic tumors and, after AMF treatment, significantly prolonged the lives of mice bearing disseminated intraperitoneal pancreatic tumors (Chapter-3). 2. Targeted cancer treatment could be achieved by engineering tumor homing cell surfaces with tumor proteases cleavable, cancer cell specific recombinant therapeutic proteins. To test this, Urokinase and Calpain (tumor specific proteases) cleavable; prostate cancer cell (CaP) specific (CaP1 targeting peptide); apoptosis inducible (Caspase3 V266ED3)- rCasp3V266ED3 chimeric protein was designed in silico. Hypothesized membrane anchored chimeric protein (rCasp3V266ED3, rMcherry red) plasmids were constructed. Membrane anchoring and activity of designed proteins were analyzed in RAW264.7 Mo/Ma and HEK293 cells in vitro. Further, Urokinase (uPA) mediated cleavage and release of rCasp3V266ED3 from engineered cells was tested (Chapter-4). Animal models for cancer therapy are invaluable for preclinical testing of potential cancer treatments. Final chapter of present report shows evidence for immune-deficient line of pigs as a model for human cancers (Chapter-5)
Gunnam, Mallikarjunareddy. "Novel anti-norovirus therapeutics." Thesis, Wichita State University, 2013. http://hdl.handle.net/10057/6818.
Full textThesis (M.S.)--Wichita State University, Fairmount College of Liberal Arts and Sciences, Dept. of Chemistry
Hill, Jonathan B. "Deoxyvariolins and polymer therapeutics." Thesis, University of Canterbury. Chemistry, 2005. http://hdl.handle.net/10092/6695.
Full textReynolds, Francis M. M. B. A. Massachusetts Institute of Technology. "InVivo Therapeutics® Corporation." Thesis, Massachusetts Institute of Technology, 2006. http://hdl.handle.net/1721.1/37231.
Full textIncludes bibliographical references (leaf 100).
To date, the primary treatment for spinal cord injuries has been the use of spinal fixation devices to create a stable environment for the spinal cord to heal. The second treatment option is to remove soft tissue near and around the spinal cord intended to reduce pressure on the spinal cord and allow the spinal cord to heal on its own. InVivo Therapeutics Corporation is a startup founded to commercialize novel science and technology that was developed through a collaborative effort between the Massachusetts Institute of Technology's Langer labs, and the department of Neuroscience at Harvard Medical School. Together they have created a patent pending medical device that will provide the first "Neuro-Tissue Engineered" implantable device for the immediate treatment of spinal cord injuries. We expect to have our first product on the market in 2010, and we will continue to work in our labs to develop a portfolio of three to four product categories in order to meet the systemic needs of the spinal cord injury patient. This thesis presents the first business plan, to commercialize this innovative treatment option.
(cont.) It is always challenging to be first to market with such an innovative product, so we have meticulously explored all relevant strategic initiatives, and tactical tasks required to bring our products to market. As the result we have developed a comprehensive business plan to ensure InVivo's success. Key components of the plan are: Introduction to InVivo Therapeutics, InVivo's business model, critical strategic analysis, functional strategies, financial analysis, and an integrative strategic framework. We have created a vision, mission, and strategic model that will lead to InVivo Therapeutics becoming a global leader in the treatment of neurological disease.
by Francis M. Reynolds.
M.B.A.
O'Malley, Jennifer A. "Improving therapeutics for Parkinson's disease." Cincinnati, Ohio : University of Cincinnati, 2009. http://rave.ohiolink.edu/etdc/view.cgi?acc_num=ucin1259079683.
Full textAdvisor: Kathy Steece-Collier. Title from electronic thesis title page (viewed Apr. 26, 2010). Keywords: Parkinson; dopamine; dyskinesia; levodopa; dendritic spine; medium spiny neuron. Includes abstract. Includes bibliographical references.
Langford, Nigel James. "Beta-receptor pharmacology and therapeutics." Thesis, University of Birmingham, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.404060.
Full textDerfus, Austin Matthew. "Toward multifunctional nanoparticle-based therapeutics." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2006. http://wwwlib.umi.com/cr/ucsd/fullcit?p3254426.
Full textTitle from first page of PDF file (viewed May 3, 2007). Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references (p. 121-135).
Sutter, Julianne V. "ASSESSING IMPACT OF AFFECT RECOGNITION ON THERAPEUTIC RELATIONSHIP." UKnowledge, 2010. http://uknowledge.uky.edu/gradschool_theses/14.
Full textChiu, Shih-Jiuan. "Receptor-mediated DNA-based therapeutics delivery." Columbus, Ohio : Ohio State University, 2005. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1127403022.
Full textBooks on the topic "Therapeutics"
A, Fronefield Stephen, ed. Therapeutics. Philadelphia: Saunders, 2000.
Find full textAgrawal, Sudhir. Antisense Therapeutics. New Jersey: Humana Press, 1996. http://dx.doi.org/10.1385/0896033058.
Full textTeicher, Beverly A. Cancer Therapeutics. New Jersey: Humana Press, 1996. http://dx.doi.org/10.1385/0896034607.
Full textPhillips, M. Ian. Antisense Therapeutics. New Jersey: Humana Press, 2004. http://dx.doi.org/10.1385/1592598544.
Full textAllerton, Charlotte, ed. Pain Therapeutics. Cambridge: Royal Society of Chemistry, 2013. http://dx.doi.org/10.1039/9781849737715.
Full textSverdlov, Oleksandr, and Joris van Dam. Digital Therapeutics. Boca Raton: Chapman and Hall/CRC, 2022. http://dx.doi.org/10.1201/9781003017288.
Full textJois, Seetharama D., ed. Peptide Therapeutics. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-04544-8.
Full textSrivastava, Ved, ed. Peptide Therapeutics. Cambridge: Royal Society of Chemistry, 2019. http://dx.doi.org/10.1039/9781788016445.
Full textVaughan, Tristan, Jane Osbourn, and Bahija Jallal, eds. Protein Therapeutics. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2017. http://dx.doi.org/10.1002/9783527699124.
Full textTeicher, Beverly A., ed. Cancer Therapeutics. Totowa, NJ: Humana Press, 1997. http://dx.doi.org/10.1007/978-1-59259-717-8.
Full textBook chapters on the topic "Therapeutics"
Louie, A. H. "Therapeutics." In IFSR International Series on Systems Science and Engineering, 223–34. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-6928-5_14.
Full textLiu, Zhanwen. "Therapeutics." In Essentials of Chinese Medicine, 321–50. London: Springer London, 2009. http://dx.doi.org/10.1007/978-1-84882-590-1_10.
Full textElliott, Peter G. "Therapeutics." In MRCGP, 64–80. London: Springer London, 1989. http://dx.doi.org/10.1007/978-1-4471-1710-0_4.
Full textMyers, Michael T. "Therapeutics." In COVID-ology, 75–102. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003310525-7.
Full textLiu, Zhanwen. "Therapeutics." In Essentials of Chinese Medicine, 321–50. London: Springer London, 2010. http://dx.doi.org/10.1007/978-1-84882-112-5_10.
Full textRosenberg, Paul A. "Therapeutics." In Endodontic Pain, 159–76. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54701-0_8.
Full textNiazi, Sarfaraz K. "RNA Therapeutics." In mRNA Therapeutics, 67–106. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003248156-4.
Full textStein, Cy A., Britta Hoehn, and John Rossi. "Oligonucleotide Therapeutics." In Principles of Anticancer Drug Development, 569–87. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-7358-0_20.
Full textSchellekens, Huub. "Recombinant Therapeutics." In Encyclopedia of Cancer, 1–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_4994-2.
Full textJain, Kewal K. "Cardiovascular Therapeutics." In Applications of Biotechnology in Cardiovascular Therapeutics, 1–27. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-240-3_1.
Full textConference papers on the topic "Therapeutics"
Anders, J. "Emerging Photobiomodulation Therapeutics." In CLEO: Applications and Technology. Washington, D.C.: OSA, 2017. http://dx.doi.org/10.1364/cleo_at.2017.atu3a.1.
Full textDormer, Kenneth, Sunny Po, Kejian Chen, Benjamin Scherlag, Isaac Rutel, Kytai Nguyen, Satish Kyriyavar, et al. "Magnetic Targeting of Therapeutics." In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13022.
Full textPires, Gabriel Natan, Ksdy Maiara Moura Sousa, Thábita Maganete, Paula Villena Redondo, and Renata Redondo Bonaldi. "SleepUp, a Digital Therapeutics Platform for Insomnia." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.296.
Full textHarris, Claire. "SP0171 THE NEW COMPLEMENT THERAPEUTICS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8492.
Full textLee, Uichin, Gyuwon Jung, Sangjun Park, Eun-Yeol Ma, Heeyoung Kim, Yonggeon Lee, and Youngtae Noh. "Data-driven Digital Therapeutics Analytics." In 2023 IEEE International Conference on Big Data and Smart Computing (BigComp). IEEE, 2023. http://dx.doi.org/10.1109/bigcomp57234.2023.00093.
Full textSwaan, Abel, Berrend B. G. Muller, Rob A. A. van Kollenburg, Daniel M. de Bruin, Dick H. J. C. M. Sterenborg, Jean J. M. C. H. de la Rosette, Ton G. van Leeuwen, and Dirk J. Faber. "One to one correlation of needle based optical coherence tomography with histopathology: a qualitative and quantitative analysis in 20 prostatectomy specimens (Conference Presentation)." In Therapeutics and Diagnostics in Urology, edited by Hyun Wook Kang and Kin Foong Chan. SPIE, 2017. http://dx.doi.org/10.1117/12.2250119.
Full textHeidari, Andrew E., Kyungjin Oh, and Zhongping Chen. "Using optical coherence tomography to detect bacterial biofilms on foley catheters (Conference Presentation)." In Therapeutics and Diagnostics in Urology, edited by Hyun Wook Kang and Kin Foong Chan. SPIE, 2017. http://dx.doi.org/10.1117/12.2251242.
Full textPham, Ngot T., Seul Lee Lee, Yong Wook Lee, and Hyun Wook Kang. "Temperature monitoring with FBG sensor during diffuser-assisted laser-induced interstitial thermotherapy (Conference Presentation)." In Therapeutics and Diagnostics in Urology, edited by Hyun Wook Kang and Kin Foong Chan. SPIE, 2017. http://dx.doi.org/10.1117/12.2251369.
Full textLurie, Kristen L., Robin Guay Lord, Caroline Boudoux, Eric J. Seibel, and Audrey K. Ellerbee. "Miniaturized rapid scanning, forward-viewing catheterscope for optical coherence tomography (Conference Presentation)." In Therapeutics and Diagnostics in Urology, edited by Hyun Wook Kang. SPIE, 2016. http://dx.doi.org/10.1117/12.2213077.
Full textSmith, Gennifer T., Kristen L. Lurie, Dimitar V. Zlatev, Joseph C. Liao, and Audrey K. Ellerbee. "Multimodal, 3D pathology-mimicking bladder phantom for evaluation of cystoscopic technologies (Conference Presentation)." In Therapeutics and Diagnostics in Urology, edited by Hyun Wook Kang. SPIE, 2016. http://dx.doi.org/10.1117/12.2213242.
Full textReports on the topic "Therapeutics"
Pitt iGEM, Pitt iGEM. Living Skin Therapeutics. Experiment, June 2014. http://dx.doi.org/10.18258/2764.
Full textPacifici, Maurizio. Preventative Therapeutics for Heterotopic Ossification. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada612073.
Full textChakraborty, Srijani. The Dawn of RNA Therapeutics. Spring Library, December 2020. http://dx.doi.org/10.47496/sl.blog.19.
Full textLillo, Antonietta. Preparedness: surveillance, diagnostics, and therapeutics. Office of Scientific and Technical Information (OSTI), September 2023. http://dx.doi.org/10.2172/2005766.
Full textPrasad, Rajeev Ram. Physiotherapy, Gamification and Digital Therapeutics. Ames (Iowa): Iowa State University, May 2024. http://dx.doi.org/10.31274/cc-20240624-1123.
Full textPapisov, Mikhail. Viral Oncolytic Therapeutics for Neoplastic Meningitis. Fort Belvoir, VA: Defense Technical Information Center, July 2012. http://dx.doi.org/10.21236/ada609948.
Full textTortorella, Domenico, and Veronika Redmann. Discovery and Testing of Ricin Therapeutics. Fort Belvoir, VA: Defense Technical Information Center, June 2012. http://dx.doi.org/10.21236/ada564153.
Full textKuruppu, Kumudu D. Viral Oncolytic Therapeutics for Neoplastic Meningitis. Fort Belvoir, VA: Defense Technical Information Center, July 2012. http://dx.doi.org/10.21236/ada566647.
Full textMao, Hai-Quan. Vesicant Therapeutics Collaborative Core Research Program. Fort Belvoir, VA: Defense Technical Information Center, December 2012. http://dx.doi.org/10.21236/ada581049.
Full textKuruppu, Kumudu D. Viral Oncolytic Therapeutics for Neoplastic Meningitis. Fort Belvoir, VA: Defense Technical Information Center, July 2013. http://dx.doi.org/10.21236/ada592240.
Full text